Manufacturer: Tripada Healthcare
Pharmaceutical name: Propranolol Hydrochloride
Pack: 10 pills (20 mg)
Beloc contains Propranolol, a beta-blocker that influences cardiac function and blood circulation. This medication is prescribed for treating tremors, hypertension, angina (chest pain), heart rhythm issues, and other circulatory complications. Additionally, Beloc may be utilized to prevent and address heart attacks and to lessen the frequency and intensity of migraines.
Propranolol competes with neurotransmitters for binding at beta1 and beta2 receptors in the heart and blood vessels, resulting in a reduction of heart rate, blood pressure, and the stress on the heart following a heart attack.
Beloc is not recommended for patients with certain medical conditions, including: bronchial asthma; COPD; untreated pheochromocytoma; sinus bradycardia; cardiogenic shock; second and third-degree heart block; overt congestive heart failure; sick sinus syndrome; Raynaud’s syndrome; Prinzmetal’s angina; severe peripheral arterial disease; and metabolic acidosis.
The concurrent use of Thioridazine is also contraindicated.
Before starting Beloc, patients must inform their healthcare provider of their complete medical history and any current conditions, including muscle or nerve disorders, breathing difficulties, diabetes, low blood pressure, heart failure, heart rhythm issues, mental health disorders, kidney disease, liver disease, thyroid disorders, pheochromocytoma, and blood circulation disorders.
It is recommended to refrain from driving and engaging in activities that require full alertness, as the medication may induce dizziness. Patients should rise slowly from sitting or lying positions to avoid dizziness and reduce the risk of falling.
This medication falls under Pregnancy Category C. Animal studies have indicated potential negative effects on the fetus, but sufficient studies in pregnant women are lacking. It should only be used by pregnant women if deemed necessary and if the benefits outweigh the risks. The drug is present in breast milk and could harm a nursing infant, so a healthcare provider must be consulted before a breastfeeding woman takes this medication.
This medication may interfere with laboratory tests and cause false-positive results in tests like glaucoma screenings and cardiovascular stress tests using arbutamine. Patients should inform their physician or laboratory personnel that they are taking this medication.